
Jonathan S. Berek
Academic Appointments
Key Documents
Contact Information
-
Clinical Offices
Stanford Women's Cancer Center 900 Blake Wilbur Dr 1st Floor MC 5854 Palo Alto, CA 94304 Tel Work (650) 498-6004 Fax (650) 498-7237Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information Email Tel (650) 723-5533Alternate Contact Kerry Garcia Assistant to the Chair Email Tel Work 650-723-5533Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> Gynecologic Cancer
- Gynecologic Oncology
- Gynecologic Cancers - Gynecologic Oncology
- Ovarian Cancer
- Uterine Cancer
- Uterine Cervical Cancer
Administrative Appointments
- Laurie Kraus Lacob Professor, Stanford (2012 - present)
- Chair, Department of Obstetrics and Gynecology, Stanford University School of Medicine (2005 - present)
- Director, Stanford Women's Cancer Center, Stanford Cancer Institute (2008 - present)
Professional Education
Residency: | Harvard Medical School, Brigham & Women's Hospital MA (1979) |
Fellowship: | UCLA - School of Medicine CA (1981) |
Internship: | Harvard Medical School, Brigham & Women's Hospital MA (1976) |
Medical Education: | Johns Hopkins University School of Medicine MD (1975) |
Biomedical Sciences: | Brown University, MMS (1973) |
Board Certification: | Gynecologic Oncology, American Board of Obstetrics and Gynecology (1983) |
Community and International Work
Scientific Focus
Clinical Trials
- Not Recruiting Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer
- Not Recruiting A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies
- Recruiting A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
- Recruiting A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women
- Recruiting Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Publications
- Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer: A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO--The MIMOSA Study. J Clin Oncol. 2013; (12): 1554-61
- Long-Term Mortality Associated With Oophorectomy Compared With Ovarian Conservation in the Nurses' Health Study. Obstet Gynecol. 2013; (4): 709-716
- Cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2012: S118-29
- Current management of vulvar cancer. Hematol Oncol Clin North Am. 2012; (1): 45-62
- FOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damage. Nat Commun. 2012: 1000
- Personalizing CA125 levels for ovarian cancer screening. Cancer Prev Res (Phila). 2011; (9): 1356-9